In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia

被引：0

作者：

Tam, C. S. ^{[1
]}

机构：

[1] St Vincents Hosp, Melbourne, Vic, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2009年 / 39卷 / 12期

关键词：

FLUDARABINE PLUS CYCLOPHOSPHAMIDE; 1ST-LINE THERAPY; YOUNGER PATIENTS; TRIAL; CHOP; CAP;

D O I：

10.1111/j.1445-5994.2009.02071.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：858 / 859

页数：2

共 11 条

[1] Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial [J].

Catovsky, D. ;

Richards, S. ;

Matutes, E. ;

Oscier, D. ;

Dyer, M. J. S. ;

FBezares, R. ;

Pettitt, A. R. ;

Hamblin, T. ;

Milligan, D. W. ;

Child, J. A. ;

Hamilton, M. S. ;

Dearden, C. E. ;

Smith, A. G. ;

Bosanquet, A. G. ;

Davis, Z. ;

Brito-Babapulle, V. ;

Else, M. ;

Wade, R. ;

Hillmen, P. .

LANCET, 2007, 370 (9583) :230-239

Eichhorst, Barbara F. ;

Busch, Raymonde ;

Obwandner, Tanja ;

Kuhn-Hallek, Ingrid ;

Herschbach, Peter ;

Hallek, Michael .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1722-1731

[3] Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia [J].

Eichhorst, BF ;

Busch, R ;

Hopfinger, G ;

Pasold, R ;

Hensel, M ;

Steinbrecher, C ;

Siehl, S ;

Jäger, U ;

Bergmann, M ;

Stilgenbauer, S ;

Schweighofer, C ;

Wendtner, CM ;

Döhner, H ;

Brittinger, G ;

Emmerich, B ;

Hallek, M .

BLOOD, 2006, 107 (03) :885-891

[4]

Fenaux P, 1996, LANCET, V347, P1432

[5] COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA [J].

FISHER, RI ;

GAYNOR, ER ;

DAHLBERG, S ;

OKEN, MM ;

GROGAN, TM ;

MIZE, EM ;

GLICK, JH ;

COLTMAN, CA ;

MILLER, TP .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) :1002-1006

[6] Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997 [J].

Flinn, Ian W. ;

Neuberg, Donna S. ;

Grever, Michael R. ;

Dewald, Gordon W. ;

Bennett, John M. ;

Paietta, Elisabeth M. ;

Hussein, Mohamad A. ;

Appelbaum, Frederick R. ;

Larson, Richard A. ;

Moore, Dennis F., Jr. ;

Tallman, Martin S. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) :793-798

[7] A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia [J].

Haines, I. ;

Elliott, P. ;

Stanley, R. .

INTERNAL MEDICINE JOURNAL, 2009, 39 (04) :269-271

[8] Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients [J].

Leporrier, M ;

Chevret, S ;

Cazin, B ;

Boudjerra, N ;

Feugier, P ;

Desablens, B ;

Rapp, MJ ;

Jaubert, J ;

Autrand, C ;

Divine, M ;

Dreyfus, B ;

Maloum, K ;

Travade, P ;

Dighiero, G ;

Binet, JL ;

Chastang, C .

BLOOD, 2001, 98 (08) :2319-2325

[9] Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. [J].

Rai, KR ;

Peterson, BL ;

Appelbaum, FR ;

Kolitz, J ;

Elias, L ;

Shepherd, L ;

Hines, J ;

Threatte, GA ;

Larson, RA ;

Cheson, BD ;

Schiffer, CA .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (24) :1750-1757

[10] Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia [J].

Tam, Constantine S. ;

O'Brien, Susan ;

Wierda, William ;

Kantarjian, Hagop ;

Wen, Sijin ;

Do, Kim-Anh ;

Thomas, Deborah A. ;

Cortes, Jorge ;

Lerner, Susan ;

Keating, Michael J. .

BLOOD, 2008, 112 (04) :975-980

← 1 2 →